Utah Medical Products (UTMD)

Utah Medical Products (UTMD) Financial Statements


Utah Medical Products Financial Overview

Utah Medical Products's market cap is currently ―. The company's EPS TTM is $4.51; its P/E ratio is 15.27; and it has a dividend yield of 1.74%. Utah Medical Products is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 12.33M$ 12.51M$ 12.87M$ 12.52M$ 13.57M
Gross Profit$ 7.10M$ 7.36M$ 7.74M$ 7.84M$ 8.33M
EBIT$ 3.94M$ 4.78M$ 5.17M$ 5.12M$ 5.59M
EBITDA$ 4.98M$ 6.57M$ 6.95M$ 6.88M$ 7.34M
Net Income Common Stockholders$ 4.29M$ 3.94M$ 4.20M$ 22.19M$ 4.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 92.87M$ 88.21M$ 84.62M$ 80.91M$ 75.05M
Total Assets$ 135.46M$ 131.24M$ 130.47M$ 127.77M$ 123.87M
Total Debt$ 295.00K$ 305.00K$ 315.00K$ 328.00K$ 341.00K
Net Debt$ -92.57M$ -87.90M$ -84.30M$ -80.58M$ -74.71M
Total Liabilities$ 7.14M$ 7.54M$ -2.27M$ 9.75M$ 123.87M
Stockholders Equity$ 128.31M$ 123.70M$ 132.75M$ 118.02M$ 126.29M
Cash Flow-
Free Cash Flow$ 5.24M$ 4.93M$ 4.59M$ 6.87M$ 5.64M
Operating Cash Flow$ 5.33M$ 5.12M$ 4.91M$ 6.92M$ 5.68M
Investing Cash Flow$ -90.00K$ -186.00K$ -320.00K$ -43.00K$ -38.00K
Financing Cash Flow$ -1.07M$ -1.03M$ -1.01M$ -1.05M$ -920.00K
Currency in USD

Utah Medical Products Earnings and Revenue History

Utah Medical Products Debt to Assets

Utah Medical Products Cash Flow

Utah Medical Products Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis